Dermatopathology
Basaloid squamous cell carcinoma of the skin

https://doi.org/10.1016/j.jaad.2010.02.051Get rights and content

Background

Basaloid squamous cell carcinoma (BSCC), an aggressive tumor of the aerodigestive tract, was described over 20 years ago, and its defining histologic parameters remain largely unchanged. While rare reports have noted cutaneous metastatic deposition, primary tumors have not been previously described.

Objective

Although most cutaneous malignancies with basaloid features comprise variants of basal cell carcinomas, a subset exhibit histologic attributes suggestive of more aggressive tumors. We evaluated 3 such tumors submitted to our dermatopathology service over a 6-month period.

Methods

Immunohistochemical stains useful in differentiating the lineage of cutaneous malignancies with basaloid-appearing tumor cells were employed. Human papillomavirus (HPV) detection and typing were performed by using polymerase chain reaction and sequencing.

Results

The tumor cells expressed high molecular weight cytokeratin (34βE12) and cytokeratin 5/6 but not Ber-EP4 or bcl-2. This pattern of immunohistochemical staining and the histologic attributes of the neoplasms are inconsistent with those expected in better defined cutaneous basaloid malignancies but are characteristic of BSCC. Two of the tumors arose in the inguinal crease of middle-aged men, and two patients were known to be immunosuppressed. HPV genotype 33 was detected in the tumor tissue from both inguinal lesions.

Limitations

The number of cases available for evaluation is small and any prognostic implications therefore tenuous.

Conclusions

The differential diagnosis of cutaneous malignancies exhibiting basaloid cells should include BSCC, a tumor with an unusual pattern of immunohistochemical staining and a potentially poor prognosis.

Section snippets

Case report

A 59-year-old white woman was referred to the Vanderbilt University Dermatology Clinic for evaluation before kidney transplant surgery. In 1995 she had been diagnosed with antineutrophilic cytoplasmic antibody–positive small vessel vasculitis, which eventuated in necrotizing and crescentic glomerulonephritis. End-stage renal disease ensued despite the administration of prednisone, cyclophosphamide (Cytoxan), cyclosporine, azathioprine, and rituximab. In May 2005 a biopsy was performed on a

Discussion

BSCCs have a predilection for the supraglottis, larynx, base of the tongue, and pyriform sinus, although they have been described as arising elsewhere, including the palate, buccal cavity, nasopharynx, floor of the mouth, trachea, esophagus, and tonsils as well.4, 7, 12, 13 Aside from the upper aerodigestive tract, BSCCs have also been reported in the uterine cervix, lung, and thymus.7, 8 The most common presenting symptoms are bleeding and hoarseness. A strong association with tobacco and

References (30)

  • P. Zbaren et al.

    Basaloid squamous cell carcinoma of the head and neck

    Curr Opin Otolaryngol Head Neck Surg

    (2004)
  • P. Emmanuel et al.

    p63 immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma

    Mod Pathol

    (2005)
  • J.H. Ban et al.

    Basaloid squamous cell carcinoma of the external auditory canal: case report

    Eur Arch Oto Rhino Laryngol Head Neck

    (2007)
  • S. Begum et al.

    Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status

    Am J Surg Pathol

    (2008)
  • K. Deniz et al.

    Expression of PCNA and bcl-2 in basaloid squamous cell carcinoma of the larynx: a controlled study

    Ear Nose Throat J

    (2008)
  • Cited by (34)

    • Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: An immunohistochemical reappraisal

      2015, Annals of Diagnostic Pathology
      Citation Excerpt :

      In contrast, only 16% of BSCCs showed positive staining with that marker. That finding corroborates data in prior studies that generally showed the absence of Ber-EP4 in SCC, including its basaloid variant [2,3,33]. This observation possibly is explained by the fact that EpCAM expression is lost in terminally differentiated cells such as keratinocytes and thus is also lost in squamous carcinomas [34].

    View all citing articles on Scopus

    Funding sources: None.

    Conflicts of interest: None declared.

    View full text